• Explore /
  • Poster
  • / Clinical utility of Foundation One tissue molecular profiling in men with metastatic prostate cancer.

Clinical utility of Foundation One tissue molecular profiling in men with metastatic prostate cancer.

Abstract Poster

Authors

Jason Zhu

Jason Zhu

Duke Cancer Institute, Duke University, Durham, NC

Jason Zhu , Matthew D Tucker , Patrick Healy , Michael Sandon Humeniuk , Casey Jarvis , Daniel J. George , Andrew J. Armstrong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 318)

DOI

10.1200/JCO.2018.36.6_suppl.318

Abstract #

318

Poster Bd #

C9

Abstract Disclosures

Similar Posters

First Author: Richard Gagnon

First Author: Fadi Taza

Poster

2023 ASCO Genitourinary Cancers Symposium

<span color-m="#000000" font-m="Calibri" size-m="10pt">Clinical and molecular features of </span><em><span color-m="#000000" font-m="Calibri" size-m="10pt" italic-m="true">ATM</span></em><span color-m="#000000" font-m="Calibri" size-m="10pt"> and </span><em><span color-m="#000000" font-m="Calibri" size-m="10pt" italic-m="true">BRCA2 </span></em><span color-m="#000000" font-m="Calibri" size-m="10pt">mutations in metastatic prostate cancer.</span>

Clinical and molecular features of ATM and BRCA2 mutations in metastatic prostate cancer.

First Author: Xiaolei Shi

First Author: Santosh Gupta